Thyrocare Technologies Ltd (THYROCARE)
₹644.95
Thyrocare Technologies Ltd share Performance
- ₹632₹653.95₹644.95
2.01%
Low
Day's Volatility:3.40%
High
1.40%
- ₹442.05₹722.65₹644.95
31.46%
Low
52 Weeks Volatility:43.51%
High
12.05%
| Returns % | |
| 1 Month Return | 7.19 % |
| 3 Month Return | 5.53 % |
| 1 Year Return | 45.49 % |
| Market Stats | |
| Previous Close | ₹650.65 |
| Open | ₹650.00 |
| Volume | 51.36K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹3,445.37Cr |
Analyst Rating
based on 2 analysts
Based on 2 analysts offering long term price targets for Thyrocare Technologies Ltd. An average target of ₹727.5
Source: S&P Global Market Intelligence
Company Information
Share Price: ₹644.95 per share as on 30 Apr, 2024 04:01 PM
Market Capitalisation: ₹3,445.37Cr as of today
Revenue: ₹134.74Cr as on December 2023 (Q4 23)
Net Profit: ₹14.74Cr as on December 2023 (Q4 23)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
| Organisation | Thyrocare Technologies Ltd |
| Headquarters | Navi Mumbai |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Thyrocare Technologies Ltd
Thyrocare Founder to Invest up to Rs 50 Crore in Indian Startups - 28 Apr, 2024
Dr. Arokiaswamy Velumani, founder of Thyrocare Technologies Ltd., has partnered with Young Entrepreneurs Association and Magnifiq Capital Trust to invest up to Rs 50 crore in seed-stage startups with considerable growth potential and at least Rs 5 crore in turnover. Velumani aims to provide financial backing and mentorship to promising startups.
Thyrocare Founder Shares Journey and Lessons for Entrepreneurs - 20 Apr, 2024
A recent podcast features A. Velumani, the founder of Thyrocare Technologies Ltd, sharing his journey from humble beginnings to building a billion-dollar company. He credits his success to dedication, frugality, and the support of his wife. Despite achieving significant financial success, he continued to prioritize responsible financial management. The decision to take the company public through an IPO was pivotal in its growth trajectory, resulting in overwhelming success. Velumani shares invaluable lessons for aspiring entrepreneurs.
ICICI Securities Gives Buy Call on Thyrocare Technologies - 16 Apr, 2024
ICICI Securities has given a buy call on Thyrocare Technologies with a target price of Rs 725. The company reported a consolidated total income of Rs 137.47 crore for the quarter ended December 31, 2023, and net profit after tax of Rs 14.61 crore. Promoters held 71.11% stake in the company as of Dec 31, 2023.
Diagnostic Companies to Register 10-11% Growth in Revenue by FY2025 - 10 Apr, 2024
A study by CRISIL predicts that diagnostic companies, including Thyrocare Technologies, are set to register a growth of 10-11% in revenue by financial year 2025 due to an increase in patients and improving revenue per patient.
Fundamentals of Thyrocare Technologies Ltd
Insights on Thyrocare Technologies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 12.47% to 12.94% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 269.3% return, outperforming this stock by 305.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.11% of holdings in Mar 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Global Health Ltd has given 183.9% return, outperforming this stock by 138.4%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 150.53 Cr → 137.6 Cr (in ₹), with an average decrease of 8.6% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 20.34 Cr → 15.35 Cr (in ₹), with an average decrease of 24.5% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 3.35% to 2.90% in Mar 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, THYROCARE stock has moved down by -36.5%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 11.65% to 11.10% in Mar 2024 quarter
Thyrocare Technologies Ltd Valuation
Thyrocare Technologies Ltd in the last 5 years
Lowest (18.71x)
June 23, 2022
Today (53.16x)
April 29, 2024
Industry (92.76x)
April 29, 2024
Highest (91.79x)
October 27, 2020
Mutual Fund Holdings
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.11% | 0.00 | |
| Foreign Institutions | 2.9% | 0.00 | |
| Mutual Funds | 12.94% | 0.00 | |
| Retail Investors | 11.1% | 0.00 | |
| Others | 1.94% | 0.00 |
Technicals of Thyrocare Technologies Ltd share
News & Events of Thyrocare Technologies Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Thyrocare Technologies Ltd shares.
Thyrocare Technologies Ltd (THYROCARE) share price today is ₹644.95
Thyrocare Technologies Ltd is listed on NSE
Thyrocare Technologies Ltd is listed on BSE
- Today’s highest price of Thyrocare Technologies Ltd is ₹653.95.
- Today’s lowest price of Thyrocare Technologies Ltd is ₹632.
PE Ratio of Thyrocare Technologies Ltd is 53.16
PE ratio = Thyrocare Technologies Ltd Market price per share / Thyrocare Technologies Ltd Earnings per share
Today’s traded volume of Thyrocare Technologies Ltd(THYROCARE) is 51.36K.
Today’s market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹3445.37Cr.
| Thyrocare Technologies Ltd(THYROCARE | Price |
|---|---|
52 Week High | ₹722.65 |
52 Week Low | ₹442.05 |
Thyrocare Technologies Ltd(THYROCARE) share price is ₹644.95. It is down -10.75% from its 52 Week High price of ₹722.65
Thyrocare Technologies Ltd(THYROCARE) share price is ₹644.95. It is up 45.90% from its 52 Week Low price of ₹442.05
| Thyrocare Technologies Ltd(THYROCARE | Returns |
|---|---|
1 Day Returns | -5.7% |
1 Month Returns | 7.19% |
3 Month Returns | 5.53% |
1 Year Returns | 45.49% |